Dina I. A. Othman

Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, <i>in vitro</i> and <i>in silico</i> studies

Dina I. A. Othman, Abdelrahman Hamdi, Samar S. Tawfik et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives

Dina I. A. Othman, Khalid B. Selim, Magda A.‐A. El‐Sayed et al. · Bioorganic & Medicinal Chemistry · 2019 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Design, synthesis, antitumor, and VEGFR-2 inhibition activities of novel 4-anilino-2-vinyl-quinazolines: Molecular modeling studies

Abdelrahman Hamdi, Hamed W. El-Shafey, Dina I. A. Othman et al. · Bioorganic Chemistry · 2022 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Design and Synthesis of Benzene Homologues Tethered with 1,2,4-Triazole and 1,3,4-Thiadiazole Motifs Revealing Dual MCF-7/HepG2 Cytotoxic Activity with Prominent Selectivity via Histone Demethylase LSD1 Inhibitory Effect

Mosa Alsehli, Ateyatallah Aljuhani, Saleh Ihmaid et al. · International Journal of Molecular Sciences · 2022 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and <i>in silico</i> insights

Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A Ewes et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17